National Healthcare (NHC) FY2020 results: revenue $1.0 billion, up 3.2% on the year
National Healthcare Corp. (NHC) reported revenue of $1.0 billion for fiscal 2020, the year ended 31 December 2020, up 3.2% on the year before. Net income was $42 million, down 38.6%, and diluted earnings per share $2.72. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2021.
Revenue
$1.0 billion
+3.2% on the year
FY2016FY2020
Operating margin
4.7%
4.9% a year earlier
FY2016FY2020
Net income
$42 million
-38.6% on the year
FY2016FY2020
Diluted EPS
$2.72
-38.7% on the year
FY2016FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
1,028
996
980
+3.2%
Operating income
48.2
49.0
56.1
-1.8%
Operating margin
4.7%
4.9%
5.7%
Interest expense
1.4
3.1
4.7
-55.4%
Income tax
10.4
20.0
16.2
-47.9%
Net income
41.9
68.2
59.0
-38.6%
Net margin
4.1%
6.8%
6.0%
Diluted EPS
$2.72
$4.44
$3.87
-38.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
203
100
98.4
+103.0%
Capital expenditure
21.9
26.4
29.8
-17.1%
Free cash flow
181
73.7
68.7
+146.1%
Free cash flow margin
17.6%
7.4%
7.0%
Cash from investing
-63.9
-14.3
-33.7
Cash from financing
-41.9
-79.7
-77.3
Depreciation and amortisation
42.0
42.4
41.9
-0.9%
Share-based compensation
2.5
1.9
1.8
+30.6%
Buybacks
0.1
0.9
0.9
-93.9%
Dividends paid
31.9
31.2
29.8
+2.3%
Dividend per share
$2.08
$2.06
$1.98
+1.0%
Diluted shares, weighted
15m
15m
15m
+0.1%
Shares outstanding at period end
15m
15m
15m
+0.2%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
795
779
733
+2.1%
Non-controlling interest
3.1
0.5
1.2
+547.7%
Debt
0.0
10.0
55.0
Operating lease liabilities
154
179
0.0
-14.0%
Finance lease liabilities
10.5
15.0
19.1
-29.6%
Other liabilities
400
304
272
+31.5%
Total liabilities and equity
1,362
1,287
1,081
+5.9%
Fixed assets
520
535
535
-2.8%
Goodwill
21.3
21.0
21.0
+1.6%
Intangible assets
0.0
n/a
n/a
Investments
n/a
279
294
Securities held for sale or to maturity
190
n/a
n/a
Cash and equivalents
147
50.3
43.2
+192.2%
Receivables
89.7
93.0
97.3
-3.6%
Inventory
8.8
7.4
7.5
+18.0%
Other assets
385
300
83.2
+28.3%
Total assets
1,362
1,287
1,081
+5.9%
10-K for the year ended 31 December 2020, filed 19 February 2021: the filing.